These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5874785)

  • 1. [Effect of a methylhydrazine derivative, Ro 4-6467, in Hodgkin's disease, in other malignant lymphomas and in leukemias].
    Kenis Y; Werli J; Hildebrand J; Tagnon HJ
    Eur J Cancer (1965); 1965 Jun; 1(1):33-40. PubMed ID: 5874785
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trial of treatment of Hodgkin's disease and other lymphomas with a methylhydrazine, p-(N'-methylhydrazinomethyl)-N-isopropylbenzamide hydrochloride].
    Berumen L; Franco Guevara G
    Rev Med Hosp Gen (Mex); 1965 Mar; 28(3):175-82. PubMed ID: 5318927
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
    da Silva MP; Kerbauy J; de Guerra CC
    Rev Bras Med; 1966 Jul; 23(7):483-9. PubMed ID: 6014416
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytostatic therapy of hemoblastoses and malignant tumors with a methylhydrazine derivative].
    Kühböck J; Mannheimer E; Pietschmann H
    Wien Klin Wochenschr; 1966 Dec; 78(48):841-4. PubMed ID: 4291623
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methylhydrazine in Hodgkin's disease in reticulosarcoma].
    Finotto E; Grigoletto E; Fiorentino M
    Cancro; 1968; 21(2):165-84. PubMed ID: 4888045
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methylhydrazine in the therapy of malignant lymphopathies].
    Beltrametti L; Almici C
    Policlinico Prat; 1967 Jan; 74(3):82-5. PubMed ID: 4878309
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1966 May; 116(21):468-71. PubMed ID: 4863533
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methylhydrazine in the treatment of Hodgkin's disease].
    Sartoris S; Bachi C; Blefari D; Cavallero P; Vergnano F; Fazio M
    Minerva Med; 1968 Jan; 59(7):296-300. PubMed ID: 5638686
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hodgkin's disease and hematosarcomas. Treatment trial by 2 methylhydrazines].
    Mathe G; Schneider M; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR
    Concours Med; 1965 Jul; 87(27):4555-62. PubMed ID: 5841618
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of the effect of a methylhydrazine derivative in Hodgkin's disease].
    Bichel J; Jensen KB
    Folia Clin Int (Barc); 1967 Apr; 17(4):179-87. PubMed ID: 5607141
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of lymphomas with methyl-hydrazine (Ro 4-6467/1, MIH, "Natulanar")].
    de Oliveira HP; Atten MT
    Hospital (Rio J); 1966 Sep; 70(3):651-69. PubMed ID: 4867575
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methylhydrazine in the treatment of multiple myeloma and Hodgkin's disease].
    Clément F
    Schweiz Med Wochenschr; 1965 Oct; 95(43):1431-4. PubMed ID: 5880926
    [No Abstract]   [Full Text] [Related]  

  • 13. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of malignant systemic diseases with a methylhydrazine derivative, Natulan].
    Nissen I; Poulsen EH
    Ugeskr Laeger; 1967 Nov; 129(44):1472-6. PubMed ID: 4875225
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Hodgkin's disease with vincaleukoblastine and methylhydrazine. (Preliminary note)].
    Grozea P; Geib R; Sighetea E; Gociu M; Dăncescu I; Berceanu S
    Stud Cercet Med Interna; 1966; 7(5):483-8. PubMed ID: 5965810
    [No Abstract]   [Full Text] [Related]  

  • 16. [Further observations concerning the results of treatment of Hodgkin's disease and lymphosarcoma with methylhydrazine].
    Lawkowicz W; Krzemińska-Lawkowiczowa ; Kolakowska-Polubiec K; Polubiec A
    Wiad Lek; 1970 Aug; 23(16):1419-22. PubMed ID: 5468885
    [No Abstract]   [Full Text] [Related]  

  • 17. [Association of nitrogen mustard, vincristine, methylhydrazine and prednisone in treatment of diffuse forms of Hodgkin's disease and ganglionic sarcomas].
    Goudemand M; Sautière-Habay D; Bauters F; Lerche-Habart B
    Lille Med; 1968 Dec; 13(10):1102-7. PubMed ID: 4886051
    [No Abstract]   [Full Text] [Related]  

  • 18. [TRIAL TREATMENT BY A METHYLHYDRAZINE OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS AND LEUKEMIAS].
    MATHE G; BERUMEN L; SCHWEISGUTH O; BRULE G; SCHNEIDER M; AMIEL JL; SCHWARZENBERG L
    Nouv Rev Fr Hematol; 1964; 4():327-9. PubMed ID: 14148296
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of some chronic hemoblastoses by a derivative of methylhydrazine (Natulan)].
    Quattrin N; Montuori R
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):178-9. PubMed ID: 4968995
    [No Abstract]   [Full Text] [Related]  

  • 20. Procarbazine (Natulan) in the treatment of Hodgkin's disease and other lymphomas.
    Spies SK; Snyman HW
    S Afr Med J; 1966 Dec; 40(44):1061-4. PubMed ID: 5334208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.